Company intelligence / Profile preview

Nuri Science

Ownership: Private
Development stage: Other

Overview

Nuri Science is the first company to develop a protein-based additive for selective gender regulation in livestock and is also developing bio-protein medications targeting various diseases in companion animals. The company claims high efficacy and safety for its products but no published clinical trial results are available

Therapeutic areas: DermatologyOther
Modalities: ProteinBiologic (bio-protein formulations)
Industry: Agriculture & AgTech

Partnerships

No major pharmaceutical or biotech partnerships publicly disclosed.

Beyond the preview

Go deeper on Nuri Science.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nuri Science.

Explore the full profile